Edition:
United States

Skyline Medical Inc (SKLN.OQ)

SKLN.OQ on NASDAQ Stock Exchange Capital Market

1.05USD
3:59pm EST
Change (% chg)

$-0.02 (-1.87%)
Prev Close
$1.07
Open
$1.05
Day's High
$1.08
Day's Low
$1.00
Volume
56,625
Avg. Vol
46,033
52-wk High
$4.18
52-wk Low
$1.00

Latest Key Developments (Source: Significant Developments)

Skyline Medical Files For Resale Of Up To 1.9 Mln Shares By Selling Stockholder
Friday, 8 Dec 2017 05:40pm EST 

Dec 8 (Reuters) - Skyline Medical Inc ::SKYLINE MEDICAL INC FILES FOR RESALE OF UP TO 1.9 MILLION SHARES OF CO'S COMMON STOCK BY THE SELLING STOCKHOLDER - SEC FILING.  Full Article

Skyline Medical and Helomics Announce Joint Strategic Partnership With GLG Pharma
Tuesday, 28 Nov 2017 08:30am EST 

Nov 28 (Reuters) - Helomics Corp ::SKYLINE MEDICAL AND HELOMICS ANNOUNCE A JOINT STRATEGIC PARTNERSHIP WITH GLG PHARMA.SKYLINE MEDICAL - ‍NEW PARTNERSHIP TO FILE FOR EUROPEAN GRANT APPLICATION TO EXPAND GLG'S AND SKYLINE-HELOMICS VENTURE'S PRODUCT OFFERING​ ACROSS EUROPE.  Full Article

Skyline Medical, Helomics Corp sign joint venture to commercialize D-CHIP platform
Wednesday, 15 Nov 2017 08:30am EST 

Nov 15 (Reuters) - Helomics Corp :Skyline Medical and Helomics Corporation sign joint venture term sheet to build-out and commercialize the D-CHIP platform.Skyline Medical Inc - ‍joint venture is subject to terms and conditions, including further due diligence and financing of new entity​.Skyline Medical Inc - ‍signed a term sheet with Helomics Corporation​.Skyline Medical Inc - ‍deal to leverage Helomics D-CHIP platform to develop and market new approaches for personalized cancer diagnosis and care​.Skyline Medical Inc - ‍skyline Medical will own 51 pct of joint venture, with Helomics owning remaining 49 pct​.Skyline Medical Inc - operations of JV will be managed by Helomics subject to direction and oversight of joint venture's board of directors​.  Full Article

Skyline Medical reports Q3 loss per share $0.16
Tuesday, 14 Nov 2017 05:30pm EST 

Nov 14 (Reuters) - Skyline Medical Inc :Skyline Medical reports 2017 third quarter financial results.Q3 loss per share $0.16.Q3 revenue $152,500 versus $134,600.  Full Article

Skyline Medical partners with Device Technologies
Thursday, 9 Nov 2017 01:30pm EST 

Nov 9 (Reuters) - Skyline Medical Inc ::Says ‍has partnered with Device Technologies to market STREAMWAY System in Australia, New Zealand, Fiji and Pacific Islands​.  Full Article

Skyline Medical proposes two joint ventures
Wednesday, 8 Nov 2017 08:00am EST 

Nov 8 (Reuters) - Skyline Medical Inc :Two proposed joint ventures with Helomics Corporation and Cytobioscience​.Proposed jv with Cytobioscience, privately held biomedical co, will provide skyline with access to CYTOBIOSCIENCE' research services​.Merger agreement between co, Cytobioscience announced on Aug 9 terminated in order to focus on structuring proposed joint venture​.  Full Article

Skyline Medical signs distribution agreements in Canada and Switzerland
Tuesday, 7 Nov 2017 08:30am EST 

Nov 7 (Reuters) - Skyline Medical Inc ::Skyline Medical Inc expands international presence by signing distribution agreements in Canada and Switzerland.Skyline Medical - ‍ partnered with 2 independent distributors to support sales of co's streamway system to medical centers in Canada, Switzerland​.  Full Article

Skyline Medical reports Q2 loss per share $0.41
Monday, 14 Aug 2017 05:00pm EDT 

Aug 14 (Reuters) - Skyline Medical Inc ::Skyline Medical reports 2017 second quarter financial results.Q2 loss per share $0.41.Q2 revenue rose 25 percent to $106,800.  Full Article

Skyline Medical signs merger agreement with Cytobioscience
Wednesday, 9 Aug 2017 05:25pm EDT 

Aug 9 (Reuters) - Skyline Medical Inc ::Skyline Medical signs definitive merger agreement with Cytobioscience.Skyline Medical - upon closing of acquisition, Garvin will be named president of Skyline Medical and will be appointed to Skyline Medical board.Says acquisition has been approved by boards of directors of both companies.Skyline Medical Inc - ‍under terms of agreement, Skyline will pay owners of Cytobioscience at closing 19.8% of outstanding common shares​.Skyline Medical Inc says upon closing of acquisition Schwartz will remain chief executive officer and a director of Skyline.  Full Article

Skyline Medical signs binding letter of intent for merger transaction with Cytobioscience
Tuesday, 1 Aug 2017 09:00am EDT 

Aug 1 (Reuters) - Skyline Medical Inc :Skyline Medical signs binding letter of intent for merger transaction with Cytobioscience.Skyline Medical Inc - letter of intent is subject to entering into a definitive merger agreement.Skyline Medical Inc - Cytobioscience has reported a current backlog of $6 million in orders and anticipated contract research work.  Full Article

BRIEF-Skyline Medical Files For Resale Of Up To 1.9 Mln Shares By Selling Stockholder

* SKYLINE MEDICAL INC FILES FOR RESALE OF UP TO 1.9 MILLION SHARES OF CO'S COMMON STOCK BY THE SELLING STOCKHOLDER - SEC FILING Source text: (http://bit.ly/2BQ55m2) Further company coverage:

No consensus analysis data available.